我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

Fielder XT 导丝在功能性慢性完全闭塞病变中的应用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第2期
页码:
171-173183
栏目:
临床研究
出版日期:
2014-01-20

文章信息/Info

Title:
Clinical application of Fielder XT wire in percutaneous coronary intervention for functional chronic total occlusion
作者:
赵慧强陈 晖李虹伟李东宝姚道阔王 雷
(首都医科大学附属北京友谊医院心血管病中心心内科,北京 100050)
Author(s):
ZHAO Hui-qiang CHEN Hui LI Hong-wei LI Dong-bao YAO Dao-kuo WANG Lei
(Department of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China)
关键词:
慢性完全闭塞冠状动脉造影经皮冠状动脉介入治疗
Keywords:
chronic total occlusion coronary angiography percutaneous coronary intervention
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:总结Fielder XT导丝在功能性慢性完全闭塞(CTO)病变介入治疗中的使用体会和经验。方法: 回顾分析我科2011年1月~2012年10月住院使用过Fielder XT导丝行介入治疗的CTO病变患者的影像资料。根据CTO病变的影像特点将患者分为绝对性CTO病变组和功能性CTO病变组,分别统计上述两组的CTO病变经皮冠状动脉介入治疗(PCI)成功率,统计两组的Fielder XT导丝的CTO病变通过率,并进行比较分析。结果: 功能性CTO病变组和绝对性CTO病变组CTO病变的成功率分别为89%、60%(40/45、22/37,P<0.01);两组Fielder XT导丝的通过率分别为:71%、24%(32/45、9/37,P<0.01)。结论: Fielder XT在功能性CTO病变中有较高的导丝通过率。
Abstract:
AIM:To summarize the application experience of percutaneous coronary intervention (PCI) using Fielder XT wire in treating patients with functional chronic total occlusion (CTO) lesion. METHODS: Data were retrospectively analyzed in patients with CTO who were treated by PCI using Fielder XT wire between January 2011 and October 2012. The success rates of PCI for CTO and the success rates of Fielder XT passing through CTO were, respectively, calculated in patients with functional CTO and with true CTO. RESULTS: The success rates of PCI for functional CTO and for true CTO were, respectively, 88.9% vs. 59.5% (40/45, 22/37, P<0.01) and the success rates of Fielder XT passing through CTO were, respectively, 71.1% vs. 24.3% (32/45, 9/37, P<0.01). CONCLUSION: The success rate of Fielder XT in passing through functional CTO is higher than in passing through true CTO. Fielder XT may be the preferred guide wire for functional CTO lesion.

参考文献/References

[1]Kahn JK.Angiographic suitability for catheter revascularization of total coronary occlusions in patients from a community hospital setting[J].Am Heart J,1993,126 (3 Pt 1):561-564.
[2]Stone GW,Kandzari DE,Mehran R,et al.Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I[J].Circulation,2005,112(15): 2364-2372.
[3]Surmely JF,Tsuchikane E,Katoh O,et al.New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique[J].J Invasive Cardiol,2006,18(7):334-338.
[4]Segev A,Strauss BH.Novel approaches for the treatment of chronic total coronary occlusions[J].J Interv Cardiol,2004,17(6):411-416.
[5]Reifart N,Enayat D,Giokoglu K,et al.A novel penetration catheter(Tornus)as bail-out device after balloon failure to recanalise long, old calcified chronic occlusions[J].EuroIntervention,2008,3(5):617-621.
[6]Whitlow PL,Burke MN,Lombardi WL,et al.Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs(Facilitated Antegrade Steering Technique in Chronic Total Occlusions)trial[J].JACC Cardiovasc Interv,2012,5(4):393-401.
[7]Surmely JF,Katoh O,Tsuchikane E,et al.Coronary septal collaterals as an access for the retrograde approach in the percutaneous treatment of coronary chronic total occlusions[J].Catheter Cardiovasc Interv,2007,69(6):826-832.
[8]Patel VG,Brayton KM,Tamayo A,et al.Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies[J].JACC Cardiovasc Interv,2013,6(2):128-136.
[9]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-24.
[10]Bufe A,Haltern G,Dinh W,et al.Recanalisation of coronary chronic total occlusions with new techniques including the retrograde approach via collaterals[J].Neth Heart J,2011,19(4):162-167.

备注/Memo

备注/Memo:
收稿日期:2013-06-23.
通讯作者:陈晖,主任医师,主要从事冠心病研究Email:Chenhui8706@yahoo.com.cn
作者简介:赵慧强,副主任医师,博士Email:dr.zhaohq@gmail.com
更新日期/Last Update: 2014-01-16